Drugs / 99mTc sulfur colloid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01677338 | Jul 2013 → Jun 2014 | dyspepsia | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02112240 | May 2013 → Feb 2017 | rectal cancer | University of Virginia | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-sulfur colloid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02112240 ↗ |
| Modality | Diagnostic / imaging agent | “the use of a radiotracer (Tc-sulfur colloid), a dye (Spot), and imaging” NCT02112240 ↗ |
| Route | Oral | “PO, the Solid Test Meal containing 500 uCi 99mTc sulfur colloid. Perform the Scintigraphy.” NCT01677338 ↗ |